What is the equity of Zymeworks this year?
Zymeworks has equity of 464.81 M USD this year.
Zymeworks Equity 2024
Zymeworks Equity
464.81 M USD
Ticker
ZYME
ISIN
CA98985W1023
WKN
A2DP0F
In 2024, Zymeworks's equity was 464.81 M USD, a -5.72% increase from the 493 M USD equity in the previous year.
Zymeworks Aktienanalyse
What does Zymeworks do?
Zymeworks Inc is a biotechnology company that was founded in 2003. The company is headquartered in Vancouver, Canada. The founders of the company were a group of researchers specializing in the development of antibodies. Their goal was to develop a platform technology that allows for the design and production of highly specific and effective antibodies. Zymeworks Inc's platform technology is based on the use of protein engineering technologies such as Immunoglobulin G competences (IgG). This allows for the targeted production of antibodies that bind to specific target molecules. The business model of Zymeworks Inc is based on licensing its platform technology to other companies. The licensees use Zymeworks' platform to develop antibodies or other proteins for their own pharmaceutical research. Zymeworks Inc has various business areas that specialize in the different applications of its platform technology. This includes cancer immunotherapy, the treatment of autoimmune diseases, and the development of biological therapeutics. The company also offers products that can be used directly by patients, such as a test kit for determining the risk of breast cancer. Over the years, Zymeworks Inc has expanded its business areas and formed partnerships with major pharmaceutical companies. In summary, Zymeworks Inc is a leading biotechnology company specializing in the development of antibodies and other proteins. It has a unique platform technology that allows its customers to develop targeted antibodies and therapeutic proteins. Its products are used in various areas, including cancer immunotherapy, the treatment of autoimmune diseases, and biological therapeutics. Zymeworks ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Zymeworks's Equity
Zymeworks's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Zymeworks's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Zymeworks's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Zymeworks's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Zymeworks’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Zymeworks stock
What was the equity of Zymeworks compared to the previous year?
The equity of Zymeworks has increased/decreased by -5.72% decreased compared to the previous year.
What impact does a high equity have on investors of Zymeworks?
A high equity is advantageous for investors of Zymeworks as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Zymeworks?
A low equity can be a risk for investors of Zymeworks, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Zymeworks affect the company?
An increase in equity of Zymeworks can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Zymeworks affect the company?
A reduction in equity of Zymeworks can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Zymeworks?
Some factors that can affect the equity of Zymeworks include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Zymeworks so important for investors?
The equity of Zymeworks is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Zymeworks take to change the equity?
To change equity, Zymeworks can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Zymeworks pay?
Over the past 12 months, Zymeworks paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Zymeworks is expected to pay a dividend of 0 USD.
What is the dividend yield of Zymeworks?
The current dividend yield of Zymeworks is .
When does Zymeworks pay dividends?
Zymeworks pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Zymeworks?
Zymeworks paid dividends every year for the past 0 years.
What is the dividend of Zymeworks?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Zymeworks located?
Zymeworks is assigned to the 'Health' sector.
Wann musste ich die Aktien von Zymeworks kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Zymeworks from 10/4/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/4/2024.
When did Zymeworks pay the last dividend?
The last dividend was paid out on 10/4/2024.
What was the dividend of Zymeworks in the year 2023?
In the year 2023, Zymeworks distributed 0 USD as dividends.
In which currency does Zymeworks pay out the dividend?
The dividends of Zymeworks are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Zymeworks
Our stock analysis for Zymeworks Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Zymeworks Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
